IMB-201

N/A

Report date: 2025/06/26 16:54:58

Base Information

Drug NameIMB-201

Drug Alias NameIMB-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-HLA class I histocompatibility antigen, alpha chain GAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulants

TargetsHLA class I histocompatibility antigen, alpha chain G

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIMBiologics Corp

China Registration ClassN/A

Develop Information

Active CompaniesIMBiologics Corp

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A